|
Dr. Handler was previously the Vice President of Research and Development for Dermik Laboratories, the dermatology unit of Sanofi-Aventis Pharmaceuticals. In this role he was responsible for all aspects of drug identification and development for dermatological use, including oversight of early compound assessment, analytical and formulation work, preclinical and clinical studies, regulatory activities and technical support of marketed products. Dr. Handler has over 16 years of experience in the pharmaceutical industry in positions of increasing responsibility in SmithKline Beecham (now GlaxoSmithKline), DuPont Pharmaceuticals (now Bristol-Myers Squibb), Ono Pharma USA and Dermik Laboratories/Sanofi-Aventis Pharmaceuticals. He has worked in a variety of therapeutic areas, including inflammation, diabetes, Alzheimer's disease, stroke, incontinence, acne and aesthetic dermatology.Dr. Handler received his PhD in pharmacology from the University of North Carolina at Chapel Hill in 1987, and an MBA from Villanova University in 2005. He is also a Diplomate of the American Board of Toxicology. | 